West Penn Allegheny Health System said Wednesday it recruited two top cancer surgeons from rival UPMC.
Dr. Blair Jobe, a general surgeon and esophageal disease specialist, will chair West Penn Hospital's Department of Surgery. He will also be director of West Penn Allegheny's new Institute for the Treatment of Esophageal and Thoracic Disease.
Jobe, who is an expert in the use of minimally invasive techniques to treat esophageal cancer and gastric disorders, will start working for West Penn Allegheny July 1.
Dr. Howard Edington, who has held several leadership roles at UPMC-affiliated hospitals, will chair the system's Department of Surgery and Director of the West Penn Allegheny Cutaneous Oncology Center. Edington, who specializes in wound healing and the surgical treatment of skin and breast cancer, takes over the positions in August.
West Penn Allegheny leaders said the hirings reflect their intent to strengthen the region's second largest hospital network. In November, officials announced a merger agreement with health insurer Highmark Inc. that is awaiting regulatory approvals.
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.